Loopbaan van Nicholas Vlahakis
Eerdere bekende functies van Nicholas Vlahakis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| COHBAR, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 | 01-05-2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Opleiding van Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Australië | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Nicholas Vlahakis
- Ervaring
